BioRestorative Therapies Inc (BRTX)
1.30
-0.08
(-5.80%)
USD |
NASDAQ |
May 17, 16:00
1.27
-0.03
(-2.31%)
After-Hours: 20:00
BioRestorative Therapies Enterprise Value: -2.251M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | -2.251M |
May 16, 2024 | -1.710M |
May 15, 2024 | -1.777M |
May 14, 2024 | -1.845M |
May 13, 2024 | -2.183M |
May 10, 2024 | -1.777M |
May 09, 2024 | -1.371M |
May 08, 2024 | -1.439M |
May 07, 2024 | -1.100M |
May 06, 2024 | -1.033M |
May 03, 2024 | -1.811M |
May 02, 2024 | -1.168M |
May 01, 2024 | -1.777M |
April 30, 2024 | -1.439M |
April 29, 2024 | -2.657M |
April 26, 2024 | -2.590M |
April 25, 2024 | -2.725M |
April 24, 2024 | -2.454M |
April 23, 2024 | -1.980M |
April 22, 2024 | -1.710M |
April 19, 2024 | -1.777M |
April 18, 2024 | -1.303M |
April 17, 2024 | -1.642M |
April 16, 2024 | -2.183M |
April 15, 2024 | -2.116M |
Date | Value |
---|---|
April 12, 2024 | -1.980M |
April 11, 2024 | -2.150M |
April 10, 2024 | -2.251M |
April 09, 2024 | -2.386M |
April 08, 2024 | -2.386M |
April 05, 2024 | -2.048M |
April 04, 2024 | -1.980M |
April 03, 2024 | -2.183M |
April 02, 2024 | -2.048M |
April 01, 2024 | -1.574M |
March 28, 2024 | -1.710M |
March 27, 2024 | -1.624M |
March 26, 2024 | -1.574M |
March 25, 2024 | -1.574M |
March 22, 2024 | -1.642M |
March 21, 2024 | -2.048M |
March 20, 2024 | -1.845M |
March 19, 2024 | -1.872M |
March 18, 2024 | -1.938M |
March 15, 2024 | -2.331M |
March 14, 2024 | -2.528M |
March 13, 2024 | -2.462M |
March 12, 2024 | -2.397M |
March 11, 2024 | -2.659M |
March 08, 2024 | -2.462M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.144M
Minimum
Jan 27 2022
67.92M
Maximum
Oct 29 2020
8.146M
Average
7.175M
Median
Feb 07 2020
Enterprise Value Benchmarks
Palatin Technologies Inc | 22.26M |
Flora Growth Corp | 11.58M |
Dominari Holdings Inc | 5.622M |
Adial Pharmaceuticals Inc | 3.458M |
Longeveron Inc | -2.144M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.825M |
Revenue (Quarterly) | 0.0193M |
Total Expenses (Quarterly) | 3.24M |
EPS Diluted (Quarterly) | -0.57 |
Profit Margin (Quarterly) | -14.64K% |
Earnings Yield | -270.0% |
Normalized Earnings Yield | -270.00 |